APOE and frontotemporal dementia: In particular, regarding genes in relation to lipid metabolic regulation, the genetic variants for the APOE gene [115] have a role in determining clinical forms of FTD, with APOE2 being protective and APOE4 increasing the risk of FTD, although these associations have not been entirely reproducible [116].